Monte Rosa Therapeutics (GLUE) Stock
Monte Rosa Therapeutics (GLUE) closed at $9.07 on Nov 17, 2026; its Tenet Score is 66 of 100 against 340 Healthcare peers.
21 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $9.07
- Nov 17, 2026
- Market cap
- $782.7M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 8.95 – 25.77
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 66/100
- Solid · 340 Healthcare peers
Industry: Drugs
Monte Rosa Therapeutics Inc scores 66/100. Solid. Strongest on value and financial health, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 66 is built from 3 of 4 pillars, from 50% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecu…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Corvus Pharmaceuticals IncCRVS | 52 | $894.1M |
| Pharming Group N.V.PHAR | 40 | $883.4M |
| MeiraGTx Holdings plcMGTX | 69 | $854.2M |
| Syndax Pharmaceuticals IncSNDX | 49 | $815.3M |
| Collegium Pharmaceutical IncCOLL | 60 | $790.2M |
| Lexicon Pharmaceuticals IncLXRX | 41 | $779.2M |
| Ardelyx IncARDX | 46 | $771.7M |
| Annexon IncANNX | 37 | $733.7M |
| Universe Pharmaceuticals INCUPC | 62 | $674.7M |
| Janux Therapeutics IncJANX | 74 | $668.1M |
Common questions
What sector and industry is Monte Rosa Therapeutics in?
Monte Rosa Therapeutics is in the Healthcare sector and the Drugs industry.
What is Monte Rosa Therapeutics' Tenet Score?
Monte Rosa Therapeutics' Tenet Score is 66 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




